4//SEC Filing
Cara Therapeutics, Inc. 4
Accession 0001209191-15-066966
$TVRDCIK 0001346830operating
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:03 PM ET
Size
5.1 KB
Accession
0001209191-15-066966
Insider Transaction Report
Form 4
Schoell Josef
Chief Financial Officer
Transactions
- Purchase
Common Stock
2015-08-18$22.10/sh+3,000$66,300→ 28,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.05 - $22.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001346830
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:03 PM ET
- Size
- 5.1 KB